Skip to content


BMC Geriatrics

Open Access

Quality of life in elderly patients after inguinal hernioplasty

  • Rosalia Patti1,
  • Emanuele Picone1,
  • Paolo Aiello1,
  • Sergio Sammartano1,
  • Giovanni Migliore1 and
  • Gaetano Di Vita1
BMC Geriatrics20099(Suppl 1):A34

Published: 1 April 2009

Background and aim

Inguinal hernia is the most frequent abdominal wall hernias in elderly population. Surgical treatment must be aware of the cardiovascular and respiratory disease these patients are often affected by. Inguinal hernia is responsible to impair the quality of life (QoL). Aim of this study was to evaluate the QoL through the Short-Form (SF)-36 questionnaire in a cohort of elderly patients undergoing inguinal hernioplasty.

Materials and methods

Fifteen male patients of age ≥75 years affected by symptomatic unilateral uncomplicated inguinal hernia were included in this study. All patients undergoing inguinal hernioplasty in local anaesthesia according to the Liechtenstein technique. The SF-36 questionnaire was administered to each patient the day before and 6 months after surgery. Global analysis of the 8 domains of SF-36 and 2 comprehensive indexes of SF-36, Physical Component Summary (PCS) and Mental Component Summary (MCS) were performed.


Inguinal hernioplasty originated no postoperative complications, in particular no patients complained of chronic pain after surgery. Six months after surgery, all 8 domains of SF-36, and MCS and PCS scores improved remarkably as compared with the preoperative time.


Inguinal hernioplasty in elderly patient is a safe and effective procedure. Although the major surgical stress observed in these subjects, the improvement of QoL, as attested by significantly increased in SF-36 scores, represent a clear-cut indication for elective inguinal hernia repair.

Authors’ Affiliations

Department of Surgical and Oncological Sciences, Division of General Surgery, University of Palermo, Palermo, Italy


© Patti et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.